Global Eye Allergy Therapeutics Market 2019-2023
SKU ID : TNV-14252566 | Publishing Date : 15-May-2019 | No. of pages : 140
Detailed TOC of Global Eye Allergy Therapeutics Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: EYE ALLERGY: AN OVERVIEW
PART 07: PIPELINE ANALYSIS
PART 08: MARKET SEGMENTATION BY PRODUCT
Market segmentation by product
Comparison by product
Antihistamines - Market size and forecast 2018-2023
Mast cell stabilizers - Market size and forecast 2018-2023
Corticosteroids - Market size and forecast 2018-2023
Immunomodulators - Market size and forecast 2018-2023
Others - Market size and forecast 2018-2023
Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive scenario
PART 15: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Akorn Inc.
Allergan Plc
Bausch Health Companies Inc.
Novartis AG
Santen Pharmaceutical Co. Ltd.
PART 16: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 17: EXPLORE TECHNAVIO
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Facts about eye allergy
Exhibit 18: Pathophysiology of eye allergy
Exhibit 19: Pipeline landscape
Exhibit 20: Some key clinical trials: Eye allergy therapeutics
Exhibit 21: Product - Market share 2018-2023 (%)
Exhibit 22: Comparison by product
Exhibit 23: Antihistamines - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Classification of antihistamines.
Exhibit 25: Example of antihistamine ophthalmic drops
Exhibit 26: Antihistamines - Year-over-year growth 2019-2023 (%)
Exhibit 27: Mast cell stabilizers - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Examples of mast cell stabilizer ophthalmic drops
Exhibit 29: Mast cell stabilizers - Year-over-year growth 2019-2023 (%)
Exhibit 30: Corticosteroids - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Examples of corticosteroid ophthalmic drops
Exhibit 32: Side effects of corticosteroid ophthalmic drops
Exhibit 33: Corticosteroids - Year-over-year growth 2019-2023 (%)
Exhibit 34: Immunomodulators - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Examples of immunosuppressant ophthalmic drops
Exhibit 36: Immunomodulators - Year-over-year growth 2019-2023 (%)
Exhibit 37: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Examples of decongestant ophthalmic drops
Exhibit 39: Example of NSAID ophthalmic drops
Exhibit 40: Examples of artificial tears
Exhibit 41: Others - Year-over-year growth 2019-2023 (%)
Exhibit 42: Market opportunity by product
Exhibit 43: Customer landscape
Exhibit 44: Market share by geography 2018-2023 (%)
Exhibit 45: Geographic comparison
Exhibit 46: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 47: ALLEVIATE trial in allergic conjunctivitis patients
Exhibit 48: North America - Year-over-year growth 2019-2023 (%)
Exhibit 49: Top 3 countries in North America
Exhibit 50: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 51: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 52: Top 3 countries in Europe
Exhibit 53: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 54: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 55: Top 3 countries in Asia
Exhibit 56: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 57: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 58: Top 3 countries in ROW
Exhibit 59: Key leading countries
Exhibit 60: Market opportunity
Exhibit 61: Impact of allergy symptoms on professional and personal lives of patients
Exhibit 62: Pharmacologic treatment for allergic conjunctivitis
Exhibit 63: Impact of drivers and challenges
Exhibit 64: Benefits associated with SCIT
Exhibit 65: Risk factors that increase susceptibility to eye allergies
Exhibit 66: Vendor landscape
Exhibit 67: Landscape disruption
Exhibit 68: Vendors covered
Exhibit 69: Vendor classification
Exhibit 70: Market positioning of vendors
Exhibit 71: Akorn Inc. - Vendor overview
Exhibit 72: Akorn Inc. - Business segments
Exhibit 73: Akorn Inc. - Organizational developments
Exhibit 74: Akorn Inc. - Segment focus
Exhibit 75: Akorn Inc. - Key offerings
Exhibit 76: Akorn Inc. - Key customers
Exhibit 77: Allergan Plc - Vendor overview
Exhibit 78: Allergan Plc - Business segments
Exhibit 79: Allergan Plc - Organizational developments
Exhibit 80: Allergan Plc - Geographic focus
Exhibit 81: Allergan Plc - Segment focus
Exhibit 82: Allergan Plc - Key offerings
Exhibit 83: Allergan Plc - Key customers
Exhibit 84: Bausch Health Companies Inc. - Vendor overview
Exhibit 85: Bausch Health Companies Inc. - Business segments
Exhibit 86: Bausch Health Companies Inc. - Organizational developments
Exhibit 87: Bausch Health Companies Inc. - Geographic focus
Exhibit 88: Bausch Health Companies Inc. - Segment focus
Exhibit 89: Bausch Health Companies Inc. - Key offerings
Exhibit 90: Bausch Health Companies Inc. - Key customers
Exhibit 91: Novartis AG - Vendor overview
Exhibit 92: Novartis AG - Business segments
Exhibit 93: Novartis AG - Organizational developments
Exhibit 94: Novartis AG - Geographic focus
Exhibit 95: Novartis AG - Segment focus
Exhibit 96: Novartis AG - Key offerings
Exhibit 97: Novartis AG - Key customers
Exhibit 98: Santen Pharmaceutical Co. Ltd. - Vendor overview
Exhibit 99: Santen Pharmaceutical Co. Ltd. - Business segments
Exhibit 100: Santen Pharmaceutical Co. Ltd. - Organizational developments
Exhibit 101: Santen Pharmaceutical Co. Ltd. - Geographic focus
Exhibit 102: Santen Pharmaceutical Co. Ltd. - Segment focus
Exhibit 103: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibit 104: Santen Pharmaceutical Co. Ltd. - Key customers
Exhibit 105: Validation techniques employed for market sizing
Exhibit 106: Definition of market positioning of vendors
Keyplayers in Global Eye Allergy Therapeutics Market 2019-2023
Akorn Inc.Allergan Plc
Bausch Health Companies Inc.
Novartis AG
Santen Pharmaceutical Co. Ltd.